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doi:10.1016/j.ejvs.2008.04.017Abstract Objectives: Little is known about the biological processes causing aortic aneurysm
rupture. Chronic Chlamydophila pneumoniae infection has been suggested as a possible con-
tributing factor to the development and expansion of abdominal aortic aneurysm (AAA). The
importance of infection in AAA may be related to the previous pathogen burden, that is, the
number of significant titres of antibodies against infectious pathogens rather than to single
infectious agents. The aim of this study was to examine the relationship between infectious
burden and AAA rupture.
Methods: In a case-control study, 119 patients with abdominal aortic aneurysm and 36
matched controls without aneurysm were prospectively investigated for specific IgG class
antibodies against C. pneumoniae, Helicobacter pylori, Cytomegalovirus, and Herpes simplex
virus.
Results: Patients with ruptured AAA have similar levels of pathogen burden as patients with
nonruptured electively operated AAA, small AAA, and controls without aneurysm.
Conclusion: The present study fails to demonstrate a connection between infectious burden
and abdominal aortic aneurysm rupture.
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ty for Vascular Surgery. PublisheIntroduction
In a recent review it was stated that little is known about
the biological processes causing abdominal aortic aneurysm
(AAA) rupture.1 Extensive infiltration of T-cells, B-cells and
macrophages are seen in biopsies from AAAs. The cause of
the inflammatory process is unknown. A possible explana-
tion for this inflammatory process is a chronic infection.d by Elsevier Ltd. All rights reserved.
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a possible contributing factor for the development and
expansion of AAA is the widespread respiratory pathogen
Chlamydophila (Chlamydia) pneumoniae. In a study by
Karlsson et al. viable C. pneumoniae was detected in the
wall of AAAs.2 However, it was concluded that the rele-
vance of C. pneumoniae infection in AAA requires further
studies to elucidate whether the infection contributes to
aneurysm formation or whether the infection is secondary
to a pre-existing aneurysm. An association exists between
smoking and ethnicity with C. pneumoniae seropositivity.3,4
These and other associations can confound the results of re-
search on the epidemiology of C. pneumoniae infections.
Furthermore, the lack of a reliable serologic marker for
chronic or persistent C. pneumoniae infection may contrib-
ute to the different results reported.5 The importance of
the single infectious agent C. pneumoniae in AAA has also
been questioned since two antibiotic trials have been
disappointing.6,7
The gastric pathogen Helicobacter pylori has been impli-
cated in the pathogenesis of atherosclerosis.8 H. pylori DNA
has been detected in human carotid atherosclerotic plaques.9
H.pylori is categorized into twophenotypesonthebasis of the
presence or absence of the CagA gene (cytotoxin-associated
gene A).10 It has been suggested that infectionwith CagA-pos-
itive H. pylori strain is more closely associated with peptic
ulcer disease.10 Recent studies have shown increased risk of
carotid atherosclerosis and coronary heart disease in subjects
harbouring CagA bearing strains of H. pylori.11,12 However,
a causal relationship between H. pylori and atherosclerosis
is not confirmed in other studies.13
An association of viral infection with atherosclerosis was
first reported by Fabricant et al., when healthy chickens in-
oculated with an avian herpesvirus were found to develop
arterial disease.14 Cytomegalovirus (CMV) has been impli-
cated in the pathogenesis of atherosclerosis.15e17 As sug-
gested for atherosclerosis the AAA risk of infection may
be related to the pathogen burden, that is, the number of
significant titres of antibodies against different infectious
pathogens rather than to single infectious agents.18,19
We hypothesised that if infectious burden was important
in the pathogenesis of AAA, the highest number of sero-
positivities to infectious pathogens ought to be in patient
with ruptured aortic aneurysm and the lowest in a control
group without aneurysm if other risk factors are eliminated.
Thus, in the present study patients with ruptured and
nonruptured AAA and matched controls were tested for
specific IgG class antibodies against Chlamydophila
pneumoniae, Helicobacter pylori, Cytomegalovirus, and
Herpes simplex 1 virus. The selected infectious pathogens
were chosen according to previous studies on
atherosclerosis.18,20,21Material and Methods
The study was performed in accordance with the principles
of the Declaration of Helsinki and was approved by the
regional ethics committee. Patients and control subjects
gave their approval by written informed consent. Controls
and patients were of the same ethnic origin and had similar
socio-economic backgrounds.AAA patients
Prospectively, we studied 119 patients with infrarenal AAA
treated at Sundsvall County Hospital between January 2002
and March 2005. Patients with coexisting clinical signs of
acute infection, or malignant disease were excluded.
Forty-one patients with ruptured infrarenal AAA (rAAA)
were included. All patients had a retroperitoneal hema-
toma confirmed at operation and underwent a temporary
initial supraceliac aortic clamping, which is the standard
approach in this institution. No blood transfusions were
given before laparotomy and in accordance with Crawford,
no significant attempt was made to blood volume resusci-
tation until the time of operation.22
Thirty-eight patients with an elective operation for
nonruptured infrarenal AAA (eAAA), with an aneurysm
diameter of at least 5.0 cm, were also included. All patients
underwent conventional open AAA repair through a standard
midline laparotomy incision and transperitoneal approach
with infrarenal graft repair.
Forty patients with asymptomatic infrarenal aortic
aneurysm on surveillance with an aneurysm diameter
smaller than 5.0 cm (small AAA) were also included.
Controls
The control group was selected in accordance with the
guidelines given by Grimes and Schulz.23 A control group of
thirty-six volunteers with normal infrarenal aortic diameter
were matched to the AAA patients according to age, gender
and smoking habits. Smoking was defined as current smok-
ing at the time of inclusion.
Imaging
The largest aortic diameter was measured using the out-
ermost ultrasonography reflection with the transducer
parallel to the longitudinal axis of the infrarenal aorta.
Normal diameter was defined as maximum infrarenal aortic
diameter <3.0 cm.24
Blood sampling
Peripheral venous blood sampleswere taken fromcontrols and
each patient preoperatively, and before any blood products
had been transfused. Samples were frozen in plastic tubes as
serum and stored at 70 C until analysis. All tests were
performed and interpreted in a blinded fashion by the same
technician, according to the manufacturers’ instructions.
Chlamydophila pneumoniae serology
Sera were tested for IgG antibodies against C. pneumoniae
using a commercial EIA kit (Euroimmun, Lu¨beck, Germany).
It is a semi-quantitative assay and the antigen used in the
EIA is SDS-extracted outer membrane protein (OMP) of ele-
mentary bodies of C. pneumoniae strain CDC/CWL-026.7 As
no international reference serum exists for antibodies
against C. pneumoniae, the calibration is performed in
relative units (RU). The manufacturer recommends inter-
preting results as positive for RU values 1.1.
Table 1 Demographics and sero-positivity of AAA patients
and controls
AAA patients
(nZ 119)
Controls
(nZ 36)
p-value
Age (years) 72 (66e78) 72 (67e78) 0.958
Sex (male) 95 (80%) 30 (83%) 0.644
Smoking 51 (43%) 15 (42%) 0.899
Serostatusa
None/one positive 4 (3%) 2 (6%) 0.916
Two positive 26 (22%) 11 (30%) 0.395
Three positive 44 (37%) 13 (36%) 0.925
Four positive 45 (38%) 10 (28%) 0.366
The figures indicate median (interquartile range) or the number
(percentage) of patients/controls, and the intergroup p-value.
a Seropositive to Chlamydophila pneumoniae, Helicobacter
pylori, Cytomegalovirus, and/or Herpes simplex 1 virus.
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The H. pylori EIA was performed as previously described.25
The EIA test results are expressed as corrected mean absor-
bance values (A 405 nm) in percent of a reference standard
(human g-globulin, Pharmacia & UpJohn, Stockholm, Swe-
den) (relative antibody activity, RAA). For H. pylori the
cut-off values are established based on EIA results obtained
with sera from patients with positive and negative gastric
cultures, healthy blood donors and children. A RAA value
of >35 was regarded as positive.
Cytomegalovirus serology
Sera were tested for IgG antibodies against CMV using
a commercial EIA kit (Euroimmun, Lu¨beck, Germany). It is
a semi-quantitative assay and the antigen used in an
inactivated cell lysate of MRC-5 cells infected with the
AD169 strain of cytomegalovirus. The manufacturer recom-
mends interpreting results as positive for RU values 0.8.
Herpes simplex 1 virus serology
Sera were tested for IgG antibodies against Herpes simplex
1 virus (HSV-1) using a commercial EIA kit (Euroimmun, Lu¨-
beck, Germany). The antigen used in an inactivated cell ly-
sate of MRC-5 cells infected with the AD169 strain of
cytomegalovirus. The calibration is performed in relative
units (RU). The manufacturer recommends interpreting re-
sults as positive for RU values 0.8.0 1 2 3 4
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Figure 1 Number of seropositivities in subgroups with abdominal
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clinical useful in the rupture risk stratification. With a stan-
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uous variables. A p-value< 0.05 was considered significant.
All analyses were carried out using SPSS statistical software
14.0 for Windows (SPSS, Chicago, Illinois, USA).
Results
There were no significant difference between all AAA
patients and controls according to age, gender and current
smoking habits (Table 1). The median (interquartile range)
aneurysm diameter were: rAAA 7.0 (6.0e8.0) cm, eAAA 5.9
(5.2e7.0) cm, and small AAA 4.0 (3.5e4.3) cm. There was
no significant difference in number of seropositivity between
the three patient groups and controls as shown in Fig. 1 (p-
valueZ 0.062, Kruskal-Wallis test). The controls show the
lowest incidence of seropositivity for all four pathogens.
However, the highest incidence of seropositivity for all path-
ogens was not in the rAAA patients but in the eAAA patients.
Discussion
The pathogenesis of AAA is not completely explained by
known risk factors for AAA (e.g., smoking, gender, age,
etc.). Therefore, the study of AAA has taken new di-
rections, one of the most intriguing of these being the
infective theory of AAA that has been addressed in recent
years. Several studies have suggested a role of C. pneumo-
niae infection in the pathogenesis of AAA, and viable C.
pneumoniae have been detected in the wall of
AAAs.2,6,7,26 However, previous studies varied greatly in
terms of population, criteria for defining AAA, size of
AAA, and adjustment for confounding variables such as
age, gender and smoking. This makes them prone to bias.
The association between C. pneumoniae infection and the
development of atherosclerosis and arterial aneurysms
remains controversial and unresolved.26e28
In the present study we investigated the possible
connection between infectious burden and AAA with special
emphasis on the identification of infectious burden as a risk
factor useful in rupture risk stratification.
The present study demonstrated a high prevalence of
seropositivity of C. pneumoniae, H. pylori, CMV, and HSV-1
in patients with AAA. However, the seroprevalence for
these infectious pathogens was similar as in controls with-
out aneurysm matched for age, gender, and smoking habits.
Furthermore, there was no significant difference in infec-
tious burden between patients with ruptured, electively
operated or small AAAs.
In summary, the present study fails to demonstrate
a connection between infectious burden (defined as sero-
positivity to Chlamydophila pneumoniae, Helicobacter py-
lori, Cytomegalovirus, and Herpes simples 1 virus) and
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